FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022713056> ?p ?o ?g. }

• W2022713056 endingPage "1076" @default.
• W2022713056 startingPage "1071" @default.
• W2022713056 abstract "OBJECTIVE To investigate the effects of TAK-802, a potent acetylcholinesterase inhibitor, and tamsulosin, an α1-adrenoceptor antagonist, and their concomitant administration on the urodynamic characteristics in a guinea-pig model of functional bladder outlet obstruction. MATERIALS AND METHODS Cystometry was performed in urethane-anaesthetized guinea pigs, and various urodynamic variables, including the maximum flow rate (Qmax), voiding efficiency, maximum intravesical pressure (Pvesmax) and intravesical pressure at Qmax (PvesQmax), were measured before and after administration of the drugs in combination and alone. RESULTS Continuous intravenous infusion of phenylephrine, an α1-adrenoceptor agonist (1–6 µg/animal/min), dose-dependently decreased the Qmax and voiding efficiency, and increased the Pvesmax and PvesQmax, possibly by constricting urethral smooth muscle. In this functional urethral constriction model, both TAK-802 at 1 and 10 µg/kg and tamsulosin at 3 and 10 µg/kg (intravenously) caused increasing effects on the Qmax and voiding efficiency. The effects were more apparent with combined exposure. Although the Pvesmax was dose-dependently increased by TAK-802 alone, the effects were completely abolished by concomitant treatment with tamsulosin. CONCLUSION These results suggest that TAK-802 and tamsulosin have synergistic effects in increasing the Qmax and voiding efficiency, and TAK-802 does not inhibit the decreasing effect of tamsulosin on urethral resistance. That TAK-802 increased Pves when administered alone implies that monotherapy using an acetylcholinesterase inhibitor should be withheld in patients with voiding dysfunction caused by obvious bladder outlet obstruction with benign prostatic hyperplasia, to avoid disorders of the upper urinary tracts, and it should be used with an α1-adrenoceptor antagonist. Whether TAK-802 combined with an α1-adrenoceptor antagonist confers additional clinical benefit is not yet known." @default.
• W2022713056 created "2016-06-24" @default.
• W2022713056 creator A5016958483 @default.
• W2022713056 creator A5036539516 @default.
• W2022713056 creator A5045809865 @default.
• W2022713056 creator A5082846927 @default.
• W2022713056 date "2005-05-01" @default.
• W2022713056 modified "2023-10-17" @default.
• W2022713056 title "Effects of TAK-802, a novel acetylcholinesterase inhibitor, and tamsulosin, an alpha1-adrenoceptor antagonist, and their synergistic effects on the urodynamic characteristics in a guinea-pig model of functional bladder outlet obstruction" @default.
• W2022713056 cites W1538654040 @default.
• W2022713056 cites W1930218819 @default.
• W2022713056 cites W1972195894 @default.
• W2022713056 cites W1977480415 @default.
• W2022713056 cites W1981173490 @default.
• W2022713056 cites W1988910337 @default.
• W2022713056 cites W1999242244 @default.
• W2022713056 cites W2002329151 @default.
• W2022713056 cites W2017353450 @default.
• W2022713056 cites W2030877235 @default.
• W2022713056 cites W2052512568 @default.
• W2022713056 cites W2062508834 @default.
• W2022713056 cites W2068097319 @default.
• W2022713056 cites W2073123650 @default.
• W2022713056 cites W2074042159 @default.
• W2022713056 cites W2080566927 @default.
• W2022713056 cites W2087132492 @default.
• W2022713056 cites W2088574114 @default.
• W2022713056 cites W2167191243 @default.
• W2022713056 cites W2413820962 @default.
• W2022713056 cites W4232665756 @default.
• W2022713056 cites W4241014291 @default.
• W2022713056 cites W4246954492 @default.
• W2022713056 cites W76461109 @default.
• W2022713056 doi "https://doi.org/10.1111/j.1464-410x.2005.05469.x" @default.
• W2022713056 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15839935" @default.
• W2022713056 hasPublicationYear "2005" @default.
• W2022713056 type Work @default.
• W2022713056 sameAs 2022713056 @default.
• W2022713056 citedByCount "7" @default.
• W2022713056 countsByYear W20227130562014 @default.
• W2022713056 countsByYear W20227130562015 @default.
• W2022713056 countsByYear W20227130562016 @default.
• W2022713056 crossrefType "journal-article" @default.
• W2022713056 hasAuthorship W2022713056A5016958483 @default.
• W2022713056 hasAuthorship W2022713056A5036539516 @default.
• W2022713056 hasAuthorship W2022713056A5045809865 @default.
• W2022713056 hasAuthorship W2022713056A5082846927 @default.
• W2022713056 hasConcept C121608353 @default.
• W2022713056 hasConcept C126322002 @default.
• W2022713056 hasConcept C126894567 @default.
• W2022713056 hasConcept C170493617 @default.
• W2022713056 hasConcept C2776235491 @default.
• W2022713056 hasConcept C2776885963 @default.
• W2022713056 hasConcept C2777562237 @default.
• W2022713056 hasConcept C2777952589 @default.
• W2022713056 hasConcept C2778938600 @default.
• W2022713056 hasConcept C2779384505 @default.
• W2022713056 hasConcept C2779478474 @default.
• W2022713056 hasConcept C2779762690 @default.
• W2022713056 hasConcept C2780070792 @default.
• W2022713056 hasConcept C2780080261 @default.
• W2022713056 hasConcept C2780542891 @default.
• W2022713056 hasConcept C42219234 @default.
• W2022713056 hasConcept C71924100 @default.
• W2022713056 hasConcept C84393581 @default.
• W2022713056 hasConceptScore W2022713056C121608353 @default.
• W2022713056 hasConceptScore W2022713056C126322002 @default.
• W2022713056 hasConceptScore W2022713056C126894567 @default.
• W2022713056 hasConceptScore W2022713056C170493617 @default.
• W2022713056 hasConceptScore W2022713056C2776235491 @default.
• W2022713056 hasConceptScore W2022713056C2776885963 @default.
• W2022713056 hasConceptScore W2022713056C2777562237 @default.
• W2022713056 hasConceptScore W2022713056C2777952589 @default.
• W2022713056 hasConceptScore W2022713056C2778938600 @default.
• W2022713056 hasConceptScore W2022713056C2779384505 @default.
• W2022713056 hasConceptScore W2022713056C2779478474 @default.
• W2022713056 hasConceptScore W2022713056C2779762690 @default.
• W2022713056 hasConceptScore W2022713056C2780070792 @default.
• W2022713056 hasConceptScore W2022713056C2780080261 @default.
• W2022713056 hasConceptScore W2022713056C2780542891 @default.
• W2022713056 hasConceptScore W2022713056C42219234 @default.
• W2022713056 hasConceptScore W2022713056C71924100 @default.
• W2022713056 hasConceptScore W2022713056C84393581 @default.
• W2022713056 hasIssue "7" @default.
• W2022713056 hasLocation W20227130561 @default.
• W2022713056 hasLocation W20227130562 @default.
• W2022713056 hasOpenAccess W2022713056 @default.
• W2022713056 hasPrimaryLocation W20227130561 @default.
• W2022713056 hasRelatedWork W1882717679 @default.
• W2022713056 hasRelatedWork W1970961371 @default.
• W2022713056 hasRelatedWork W2022713056 @default.
• W2022713056 hasRelatedWork W2061011041 @default.
• W2022713056 hasRelatedWork W2068097319 @default.
• W2022713056 hasRelatedWork W2084779778 @default.
• W2022713056 hasRelatedWork W2112292511 @default.
• W2022713056 hasRelatedWork W2159011107 @default.
• W2022713056 hasRelatedWork W2409711144 @default.
• W2022713056 hasRelatedWork W3147148232 @default.

• next